Sirolimus-A targeted therapy for Rosai-Dorfman disease

Pediatr Blood Cancer. 2019 Dec;66(12):e27994. doi: 10.1002/pbc.27994. Epub 2019 Sep 16.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use*
  • Child
  • Child, Preschool
  • Female
  • Histiocytosis, Sinus / drug therapy*
  • Histiocytosis, Sinus / pathology
  • Humans
  • Male
  • Prognosis
  • Sirolimus / therapeutic use*

Substances

  • Antibiotics, Antineoplastic
  • Sirolimus